• 1. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130

Comprehensive Overview of 8-Aminohypoxanthine (CAS No. 45893-20-7): Properties, Applications, and Research Insights

8-Aminohypoxanthine (CAS No. 45893-20-7) is a purine derivative that has garnered significant attention in biochemical and pharmaceutical research due to its unique structural properties and potential applications. This compound, chemically known as 8-amino-1H-purin-6(9H)-one, serves as a key intermediate in nucleotide metabolism and synthetic pathways. Its molecular formula, C₅H₅N₅O, and molecular weight of 151.13 g/mol make it a versatile building block for advanced studies in enzymology, drug development, and molecular biology.

In recent years, the demand for 8-Aminohypoxanthine has surged, driven by its role in cancer research, antiviral drug design, and metabolic disorder studies. Researchers frequently search for terms like "8-Aminohypoxanthine synthesis," "CAS 45893-20-7 applications," and "purine analogs in medicine," reflecting its relevance in cutting-edge science. The compound's ability to modulate enzyme activity, particularly in pathways involving xanthine oxidase and hypoxanthine-guanine phosphoribosyltransferase (HGPRT), positions it as a critical tool for investigating gout, Lesch-Nyhan syndrome, and other purine-related disorders.

From a structural perspective, 8-Aminohypoxanthine features an amino group at the 8-position of the hypoxanthine scaffold, which enhances its reactivity and binding affinity compared to unmodified hypoxanthine. This modification is pivotal for designing nucleoside analogs, a class of compounds widely explored for their antitumor and antiviral properties. Notably, its derivatives have been investigated in the context of COVID-19 therapeutics, aligning with the global focus on pandemic preparedness and broad-spectrum antiviral agents.

The synthesis of 8-Aminohypoxanthine typically involves multi-step organic reactions, including amination and cyclization processes, with yields optimized for industrial-scale production. Analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry are employed to verify its purity, which is crucial for high-throughput screening in drug discovery. Suppliers often highlight its availability as a research-grade chemical with ≥95% purity, catering to academic and industrial laboratories.

Beyond pharmaceuticals, 8-Aminohypoxanthine is utilized in agricultural biotechnology to study plant purine salvage pathways and stress responses. Its role in RNA metabolism also makes it valuable for gene expression studies and epigenetic research, areas gaining traction due to advancements in CRISPR technology and precision medicine. Environmental scientists have explored its degradation products to assess ecotoxicological impacts, addressing growing concerns about sustainable chemistry.

In conclusion, 8-Aminohypoxanthine (CAS No. 45893-20-7) exemplifies the intersection of basic science and applied research. Its multifaceted applications—from drug development to agricultural science—underscore its importance in contemporary research landscapes. As interest in personalized medicine and green chemistry grows, this compound will likely remain a focal point for innovation, answering critical questions in human health and environmental sustainability.

• 28128-41-8(8-Aminoguanine)
• 68-94-0(Hypoxanthine)
• 73-40-5(Guanine)
• 30467-02-8(8-Methyl-1H-purin-6(7H)-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)